ERAP1 and neoplasm: Similarly to murine tumor models, either pharmacological or genetic inhibition of ERAP1 impairs in vitro proliferation of the human Hh-dependent MB cell line Daoy (Supplementary Fig. 7a, b, d, e), leading to a decreased Hh-pathway activity (Supplementary Fig. 7c, f, g).